… MAE = 1.15 ± 1.80 mg/L, MRE = 11.5 ± 8.6%.Population model for piperacillin-tazobactam: R2 = 0.86, MAE = 9.31 ± 19.33 mg/L, MRE = 38.4 ± 19.5%; after …
Piperacillin-tazobactam
This drug is selected. Its supporting articles are shown below.
Articles mentioning Piperacillin-tazobactam
7 articles · page 1 of 1…e following antimicrobials under special control were reviewed: piperacillin-tazobactam, carbapenems, vancomycin, linezolid, daptomycin, voriconazole, …
…ts had difficulties accessing antibiotics, with carbapenems and piperacillin-tazobactam least accessible. 45.4% (CI 38.0% to 53.1%) had attempted to au…
…, while the most preferred in combination treatment (22.7%) was meropenem. Within the first 3 days of admittance to the ICU, 3% of patien…
…arding intracranial involvement. Initial empirical antibiotics (ceftriaxone and amikacin) were started after admission to the paediatric wa…
…robes. The patient was treated with piperacillin-tazobactam and fluconazole with a good response. E. miricola is intrinsically resistant to…
…ypertension, and hypertensive cardiomyopathy. He was started on piperacillin-tazobactam and scheduled for an above-knee amputation. Given the pulmonary…